UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Strategy Inc
MSTR
|
+$745M |
| 3 |
EA
Electronic Arts
EA
|
+$725M |
| 4 |
TotalEnergies
TTE
|
+$639M |
| 5 |
Walmart Inc
WMT
|
+$585M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.87B |
| 2 |
Apple
AAPL
|
+$1.41B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.03B |
| 5 |
Southwest Airlines
LUV
|
+$727M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.52% |
| 2 | Financials | 9.54% |
| 3 | Healthcare | 6.68% |
| 4 | Industrials | 6.61% |
| 5 | Consumer Discretionary | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
State Street SPDR S&P China ETF
GXC
$478M
| $5.18M | ﹤0.01% |
53,513
-2,607
| -5% | -$263K |
|
3977
CALL
British American Tobacco
BTI
$123B
| $5.17M | ﹤0.01% |
91,300
-64,300
| -41% | -$3.51M |
|
3978
CALL
Cognizant
CTSH
$26.3B
| $5.16M | ﹤0.01% |
62,200
| – | – |
|
3979
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$245M
| $5.15M | ﹤0.01% |
177,284
-113,959
| -39% | -$3.33M |
|
3980
Cohen & Steers REIT and Preferred and Income Fund
RNP
$974M
| $5.14M | ﹤0.01% |
259,047
-12,864
| -5% | -$267K |
|
3981
Solid Biosciences
SLDB
$927M
| $5.14M | ﹤0.01% |
911,409
+187,264
| +26% | +$1.01M |
|
3982
Oxford Industries
OXM
$549M
| $5.14M | ﹤0.01% |
150,189
+101,334
| +207% | +$3.77M |
|
3983
Kaspi.kz JSC
KSPI
$18.5B
| $5.14M | ﹤0.01% |
65,737
+43,220
| +192% | +$3.27M |
|
3984
Viridian Therapeutics
VRDN
$2.61B
| $5.13M | ﹤0.01% |
164,820
-282,857
| -63% | -$7.76M |
|
3985
CALL
Prologis
PLD
$132B
| $5.12M | ﹤0.01% |
40,100
-11,200
| -22% | -$1.4M |
|
3986
State Street SPDR Bloomberg Short Term International Treasury Bond ETF
BWZ
$288M
| $5.12M | ﹤0.01% |
186,732
-18,876
| -9% | -$515K |
|
3987
Mativ Holdings
MATV
$720M
| $5.11M | ﹤0.01% |
420,465
-267,808
| -39% | -$3.16M |
|
3988
Century Communities
CCS
$1.99B
| $5.11M | ﹤0.01% |
86,052
-26,469
| -24% | -$1.61M |
|
3989
VanEck Short Muni ETF
SMB
$314M
| $5.09M | ﹤0.01% |
292,159
-20,677
| -7% | -$359K |
|
|
IGI
3990
Western Asset Investment Grade Defined Opportunity Trust
IGI
$94.9M
| $5.08M | ﹤0.01% |
307,844
-19,596
| -6% | -$324K |
|
3991
Integra LifeSciences
IART
$1.37B
| $5.08M | ﹤0.01% |
408,969
+277,745
| +212% | +$3.69M |
|
3992
PUT
Zeta Global
ZETA
$6.88B
| $5.08M | ﹤0.01% |
249,400
+124,700
| +100% | +$2.33M |
|
3993
Simmons First National
SFNC
$3.41B
| $5.07M | ﹤0.01% |
269,141
+19,024
| +8% | +$352K |
|
3994
CALL
AT&T
T
$166B
| $5.07M | ﹤0.01% |
204,105
-827,210
| -80% | -$20.9M |
|
3995
PUT
ARK Genomic Revolution ETF
ARKG
$1.78B
| $5.07M | ﹤0.01% |
175,000
| – | – |
|
3996
Cohen & Steers
CNS
$4.42B
| $5.07M | ﹤0.01% |
80,682
-62,876
| -44% | -$4.09M |
|
3997
Jack in the Box
JACK
$347M
| $5.06M | ﹤0.01% |
267,274
-243,171
| -48% | -$4.4M |
|
3998
Monro
MNRO
$368M
| $5.06M | ﹤0.01% |
252,590
-417,480
| -62% | -$7.69M |
|
3999
Fastly Inc
FSLY
$4.44B
| $5.05M | ﹤0.01% |
496,162
-369,326
| -43% | -$3.64M |
|
4000
Phathom Pharmaceuticals
PHAT
$708M
| $5.05M | ﹤0.01% |
304,383
-33,977
| -10% | -$485K |
|
Similar funds
UBS Group's Q4 2025 Portfolio in Review
As of Q4 2025, UBS Group held 11,616 positions worth $617B, down 3.4% from $638B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group withdrew a net $32.7B in Q4 2025, closing 1,184 positions and reducing 4,502 holdings. Its most notable exit was Kellanova, an estimated $617M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Solstice Advanced Materials worth $130M.
- UBS Group's largest Q4 2025 buy was Solstice Advanced Materials: 2,681,543 shares worth $130M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $1.26B increase.
- UBS Group's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.87B.
- UBS Group fully exited Kellanova in Q4 2025, selling an estimated $617M.
- UBS Group's ten largest holdings make up 15% of its $617B portfolio in Q4 2025.
- UBS Group opened 1,319 new positions and closed 1,184 in Q4 2025.
- UBS Group's portfolio value fell 3.4% quarter-over-quarter to $617B.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.